Immunological adjuvant efficacy of glycyrrhetinic acid liposome against Newcastle disease vaccine

Vaccine

Volumn 29, Issue 52, 2011, Pages 9611-9617

  Zhao, Xiaojuan ^a   Fan, Yunpeng ^a   Wang, Deyun ^a   Hu, Yuanliang ^a   Guo, Liwei ^a   Ruan, Shiliang ^a   Zhang, Jing ^a   Yuan, Ju ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Glycyrrhetinic acid liposome; Immunoglobulins; Lymphocyte proliferation; Lymphocyte subpopulations; Serum antibody titer

Indexed keywords

GLYCYRRHETINIC ACID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGICAL ADJUVANT; LIPOSOME; NEWCASTLE DISEASE VACCINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRUG MEGADOSE; ENCAPSULATION; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; NEWCASTLE DISEASE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CHICKENS; DRUG CARRIERS; GLYCYRRHETINIC ACID; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LIPOSOMES; NEWCASTLE DISEASE; VIRAL VACCINES;

EID: 82555187050     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.10.053     Document Type: Article

References (38)

1. Tom A.B., Jennifer C., Andrew W.H. Co-stimulatory agonists as immunological adjuvants. Vaccine 2006, 24:3399-3407.
2. Aguilar J.C., Rodríguez E.G. Vaccine adjuvants revisited. Vaccine 2007, 25:3752-3762.
3. Lindblad E.B. Aluminium adjuvants-in retrospect and prospect. Vaccine 2004, 22:3658-3668.
4. Rönnberg B., Fekadu M., Morein B. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix. Vaccine 1995, 14:1375-1382.
5. Ye Y.P., Chen F.Y., Sun H.X., Li X.Y., Xu S.F. Stemucronatoside K, a novel C21 steroidal glycoside from Stephanotis mucronata, inhibited the cellular and humoral immune response in mice. Int Immunopharmacol 2008, 9:1231-1238.
6. Caroline D.S., Philip S. Saponin-adjuvanted particulate vaccines for clinical use. Methods 2006, 40:53-59.
7. Lu Y., Li J., Wang G.J. In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid. Int J Pharm 2008, 356:274-281.
8. Doll R., Hill I.D., Hutton C., Underwood D.J. Clinical trial of a triter-penoid liquorice compound in gastric and duodenal ulcer. Lancet 1962, 280:793-796.
9. Ohuchi K., Kamada Y., Levine L., Tsurufuji S. Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats. Prostaglandins Med 1981, 7:457-463.
10. Ito M., Sato A., Hirabayashi K., Tanabe F., Shigeta S., Baba M., et al. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV). Antiviral Res 1988, 10:289-298.
11. Abe N., Ebina T., Ishida N. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol Immunol 1982, 126:535-539.
12. Edwards C.R., Burt D., Mcintyre M.A., DeKloet E.R., Stewart P.M., Brett L., et al. Localisation of 11-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 1988, 332:986-989.
13. Christian G., Gry S., Ragnar H., Sigrid L.F., Jo K. Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity. Int J Pharm 2002, 233:131-140.
14. Takuya I., Shinobu W., Hiroshi K. Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome-entrapped antigen. Dev Comp Immunol 2003, 27:413-421.
15. Gregory G., Ihsan G., Mayda G., Brenda M.C. Liposomes as immunological adjuvants and vaccine carriers. J Control Release 1996, 41:49-56.
16. Gregoriadis G. Liposomes as immunological adjuvants. Theor Appl Adju. 1994, vol. 14:5-69. Wiley J, Chichester.
17. Gregoriadis G. Immunological adjuvants: a role for liposomes. Immunology 1990, 11:89-97.
18. Harrington K.J. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled PEGylated liposomes. Clin Cancer Res 2001, 7:243-254.
19. Harrington K.J., Syrigos K.N., Vile R.G. Liposomally targeted cytotoxic drugs for the treatment of cancer. J Pharm Pharmacol 2002, 54:1573-1600.
20. Chen C.J., Han D.D., Cai C.F., Tang X. An overview of liposome lyophilization and its future potential. J Control Release 2010, 142:299-311.
21. Wang L., Ge X.M. Curcumin liposomes and quality evaluation studies. Food Sci Technol 2010, 35(2):203-206.
22. Kong X.F., Hu Y.L., Li X.R., Wang D.Y., Zhang B.K., Liu J.G., et al. Effects of nine Chinese herbal medicine ingredients on serum HI antibody titer after vaccination NDV IV strain vaccine in chicks. Acta Vet Zootetech Sin 2004, 4:468-472.
23. Thekisoe M.O., Mbati P.A., Bisschop S.P. Different approaches to the vaccination of free ranging village chickens against Newcastle disease in Qwa-Qwa South Africa. Vet Microbiol 2004, 101:23-30.
24. Guo Z.H., Hu Y.L., Wang D.Y., Ma X., Zhao X.N., Zhao B.K., et al. Sulfated modification can enhance the adjuvanticity of lentinan and improve the immune effect of ND vaccine. Vaccine 2009, 27:660-665.
25. Yang Z.G., Chen A.Q., Sun H.X., Ye Y.P., Fang W.H. Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice. Vaccine 2007, 25:161-169.
26. Irie T., Watarai S., Kodama H. Humoral immune response of carp (Cyprinus carpio) induced by oral immunization with liposome-entrapped antigen. Dev Comp Immunol 2003, 27:413-421.
27. Veterinary microbiology 2001, 101. Chin Agri Press, Beijing. C.P. Lu (Ed.).
28. Wang C., Gao Q.Y., Sun B. IgA, IgM, IgG plasma cell change in the number and distribution of Harderian gland after Newcastle disease vaccine given intraocularly. Anim Husb Vet Sci 2002, 33(5):504-507.
29. Herr M., Bostedt H., Failing K. IgG and IgM levels in dairy cows during the periparturient period. Theriogenology 2011, 75:377-385.
30. Yang H.C. Animal immunology 2003, China Agri Univ Press, p. 129.
31. Huang X.Y., Hu Y.L., Zhao X.N., Yu L., Wang J.M., Zhang F., et al. Sulfated modification can enhance the adjuvant activity of astragalus polysaccharide for ND vaccine. Carbohydr Polym 2008, 73:303-308.
32. Zhu J., Paul W.E. CD4 T cells: fates, functions, and faults. Blood 2008, 112:1557-1569.
33. Deborah M., Cytolytic B. CD4 cells: direct mediators in infectious disease and malignancy. Cell Immunol 2010, 26:289-295.
34. + T cells in chickens. Anim Husb Vet Med 2009, 4:59-62.
35. Jellison E.R., Kim S.K., Welsh R.M. Cutting edge: MHC class II-restricted killing in vivo during viral infection. J Immunol 2005, 174:614-618.
36. + T cells. Cell Immunol 2009, 257:69-79.
37. + cell anti-HIV factor (CAF). Trends Immunol 2003, 12:628-632.
38. + antiviral factor. Science 2002, 298:995-1000.